Evidence Briefs

What the Research Shows

The question, the trials that tested it, and the point where the evidence stops.

Every brief here answers one question by going to the randomized trials and meta-analyses rather than to the marketing. Each one states what was measured, in how many people, and with what certainty, and each one says plainly where the evidence runs out. That last part is the reason these exist. A finding reported without its limits is how a modest effect becomes a confident claim, and how a withdrawn guideline threshold stays in circulation for years after the body that proposed it stepped back.

Supplements under scrutiny

Compounds with enough randomized trials behind them to say something specific, which is a smaller list than the supplement aisle implies.

Practices worth getting right

Where the useful answer is not whether to do it but when, and the difference is measurable.

Markers and what they predict

Where a number is worth measuring, where it is worth treating, and why those are not the same question.

Every brief cites real, verifiable studies with linked PubMed IDs, and reports the negative findings alongside the positive ones. Where a widely repeated claim turns out to rest on very little, that is stated as plainly as the claims that hold up. These pages answer what the evidence says in general; a paid research report answers what it means for one person, their labs and their medication list.

14 pages published so far. More are being added.

Before you stack the next thing

Occasional notes on what the research supports, what interacts with what, and the questions worth asking your prescriber.

The gift arrives by email, so the box has to stay ticked to send it. After that you get what Jess is actually testing that week, and one click stops it forever.